The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Authorship diversity in global evidence synthesis in genitourinary oncology: A 1998-2022 analysis of Cochrane Reviews.
 
Atulya Aman Khosla
No Relationships to Disclose
 
Ahmad Ozair
No Relationships to Disclose
 
Nishanth Subash
No Relationships to Disclose
 
Abhishek Kumar
No Relationships to Disclose
 
Alyssa Pereslete
No Relationships to Disclose
 
Sahaam Mirza
No Relationships to Disclose
 
Shreyas S Bellur
No Relationships to Disclose
 
Rohan Garje
Research Funding - Amgen (Inst); Endocyte/Advanced Accelerator Applications (Inst); Immunomedics (Inst); Pfizer (Inst); xencor (Inst)
 
Manmeet Singh Ahluwalia
Stock and Other Ownership Interests - CytoDyn; doctible; MedInnovate Advisors LLC; MimiVax
Honoraria - Elsevier; Peerview; Prime Education; Prime Oncology
Consulting or Advisory Role - Anheart Therapeutics; Apollomics; Bayer; Bugworks; Cairn Therapeutics; Caris Life Sciences; GlaxoSmithKline; InSightec; Janssen; Menarini Group; Modifi Bio; NH TherAguix; Nuvation Bio; Prelude Therapeutics; Pyramid Biosciences; SDP Oncology; ViewRay; Voyager Therapeutics; Xoft
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst); Seagen (Inst)